The Potential of PDE5 Inhibitors, Such as AriBio’s AR1001, the Lead Clinical Candidate for Alzheimer’s Disease, Confirmed in a Recent Independent Study
SEONGNAM, South Korea--(BUSINESS WIRE)--#AR1001--A recently published research article in Nature Aging by a Cleveland Clinic…